Rezultati pretrage - Annette Langer‐Gould

Detaljiziraj rezultate
  1. 1
    Validation of the Swedish Multiple Sclerosis Register

    Validation of the Swedish Multiple Sclerosis Register od Peter Alping, Fredrik Piehl, Annette Langer‐Gould, Thomas Frisell

    Izdano 2018
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  2. 2
    Multiple sclerosis, rituximab, and COVID‐19

    Multiple sclerosis, rituximab, and COVID‐19 od Annette Langer‐Gould, Jessica B. Smith, Bonnie H. Li

    Izdano 2021
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome

    Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome od Annette Langer‐Gould, Sonu M. Brara, Brandon Beaber, Corinna Koebnick

    Izdano 2013
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    Multiple Sclerosis, Rituximab, Hypogammaglobulinemia, and Risk of Infections

    Multiple Sclerosis, Rituximab, Hypogammaglobulinemia, and Risk of Infections od Annette Langer‐Gould, Bonnie H. Li, Jessica Smith, Stanley Xu

    Izdano 2024
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Pediatric Idiopathic Intracranial Hypertension and Extreme Childhood Obesity

    Pediatric Idiopathic Intracranial Hypertension and Extreme Childhood Obesity od Sonu M. Brara, Corinna Koebnick, Amy H. Porter, Annette Langer‐Gould

    Izdano 2012
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility

    Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility od Kerstin Hellwig, Lie H. Chen, Frank Z Stancyzk, Annette Langer‐Gould

    Izdano 2016
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis

    Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis od Jessica B. Smith, Edlin Gonzales, Bonnie H. Li, Annette Langer‐Gould

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis

    Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis od Lilyana Amezcua, Jessica B. Smith, Edlin Gonzales, Samantha Haraszti, Annette Langer‐Gould

    Izdano 2020
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab

    Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab od Annette Langer‐Gould, Scott W. Atlas, Ari Green, Andrew W. Bollen, Daniel Pelletier

    Izdano 2005
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    Multiple Sclerosis, Disease-Modifying Therapies, and Infections

    Multiple Sclerosis, Disease-Modifying Therapies, and Infections od Annette Langer‐Gould, Jessica B. Smith, Edlin Gonzales, Fredrik Piehl, Bonnie H. Li

    Izdano 2023
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children

    Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children od Annette Langer‐Gould, J.L. Zhang, Joanie Chung, Y. Yeung, Emmanuelle Waubant, Yao Jianhua

    Izdano 2011
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    Racial and Ethnic Disparities in Multiple Sclerosis Prevalence

    Racial and Ethnic Disparities in Multiple Sclerosis Prevalence od Annette Langer‐Gould, Edlin Gonzales, Jessica B. Smith, Bonnie H. Li, Lorene M. Nelson

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    Rituximab, MS, and pregnancy

    Rituximab, MS, and pregnancy od Jessica B. Smith, Kerstin Hellwig, Katharina Fink, Deirdre J. Lyell, Fredrik Piehl, Annette Langer‐Gould

    Izdano 2020
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  14. 14
    Environmental and genetic risk factors for MS: an integrated review

    Environmental and genetic risk factors for MS: an integrated review od Emmanuelle Waubant, Robyn Lucas, Ellen M. Mowry, Jennifer Graves, Tomas Olsson, Lars Alfredsson, Annette Langer‐Gould

    Izdano 2019
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  15. 15
    Breastfeeding, ovulatory years, and risk of multiple sclerosis

    Breastfeeding, ovulatory years, and risk of multiple sclerosis od Annette Langer‐Gould, Jessica B. Smith, Kerstin Hellwig, Edlin Gonzales, Samantha Haraszti, Corinna Koebnick, Anny H. Xiang

    Izdano 2017
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  16. 16
    Safety of potential breast milk exposure to IFN-β or glatiramer acetate

    Safety of potential breast milk exposure to IFN-β or glatiramer acetate od Andrea I. Ciplea, Annette Langer‐Gould, Anna Ståhl, Sandra Thiel, Annette Queißer-Wahrendorf, Ralf Gold, Kerstin Hellwig

    Izdano 2020
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    Association between maternal inflammatory bowel disease and adverse perinatal outcomes

    Association between maternal inflammatory bowel disease and adverse perinatal outcomes od Darios Getahun, Michael J. Fassett, George F. Longstreth, Corinna Koebnick, Annette Langer‐Gould, Daniel Strickland, Steven J. Jacobsen

    Izdano 2014
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder

    Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder od Andrea I. Ciplea, Annette Langer‐Gould, Annick de Vries, Tiny Schaap, Sandra Thiel, Marius Ringelstein, Ralf Gold, Kerstin Hellwig

    Izdano 2020
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  19. 19
    Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses

    Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses od Kerstin Hellwig, Milena Rockhoff, Sandra Herbstritt, Nadja Borisow, Aiden Haghikia, Birte Elias-Hamp, Sylvia Menck, Ralf Gold, Annette Langer‐Gould

    Izdano 2015
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  20. 20
    Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy

    Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy od Kerstin Hellwig, Marianne Tokic, Sandra Thiel, Nina Esters, Charlotte Spicher, Nina Timmesfeld, Andrea I. Ciplea, Ralf Gold, Annette Langer‐Gould

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: